Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387420810> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W4387420810 endingPage "4186" @default.
- W4387420810 startingPage "4173" @default.
- W4387420810 abstract "Neuropathic pain(NP) has similar phenotypes but different sequential neuroinflammatory mechanisms in the pathological process. It is of great significance to inhibit the initiation of neuroinflammation, which has become a new direction of NP treatment and drug development in recent years. Mongolian drug Naru-3 is clinically effective in the treatment of trigeminal neuralgia, sciatica, and other NPs in a short time, but its pharmacodynamic characteristics and mechanism of analgesia are still unclear. In this study, a spinal nerve ligation(SNL) model simulating clinical peripheral nerve injury was established and the efficacy and mechanism of Naru-3 in the treatment of NPs was discussed by means of behavioral detection, side effect evaluation, network analysis, and experimental verification. Pharmacodynamic results showed that Naru-3 increased the basic pain sensitivity threshold(mechanical hyperalgesia and thermal radiation hyperalgesia) in the initiation of SNL in animals and relieved spontaneous pain, however, there was no significant effect on the basic pain sensitivity threshold and motor coordination function of normal animals under physiological and pathological conditions. Meanwhile, the results of primary screening of target tissues showed that Naru-3 inhibited the second phase of injury-induced nociceptive response of formalin test in mice and reduced the expression of inflammatory factors in the spinal cord. Network analysis discovered that Naru-3 had synergy in the treatment of NP, and its mechanism was associated with core targets such as matrix metalloproteinase-9(MMP9) and interleukin-1β(IL-1β). The experiment further took the dorsal root ganglion(DRG) and the stage of patho-logical spinal cord as the research objects, focusing on the core targets of inducing microglial neuroinflammation. By means of Western blot, immunofluorescence, agonists, antagonists, behavior, etc., the mechanism of Naru-3 in exerting NP analgesia may be related to the negative regulation of the MMP9/IL-1β signaling pathway-mediated microglia p38/IL-1β inflammatory loop in the activation phase. The relevant research enriches the biological connotation of Naru-3 in the treatment of NP and provides references for clinical rational drug use." @default.
- W4387420810 created "2023-10-08" @default.
- W4387420810 creator A5008313987 @default.
- W4387420810 creator A5025951726 @default.
- W4387420810 creator A5037698336 @default.
- W4387420810 creator A5040524739 @default.
- W4387420810 creator A5048995986 @default.
- W4387420810 creator A5052308910 @default.
- W4387420810 creator A5055838753 @default.
- W4387420810 creator A5067661094 @default.
- W4387420810 creator A5074455515 @default.
- W4387420810 creator A5081239726 @default.
- W4387420810 creator A5082739478 @default.
- W4387420810 creator A5085052668 @default.
- W4387420810 creator A5086815085 @default.
- W4387420810 creator A5088404626 @default.
- W4387420810 date "2023-08-01" @default.
- W4387420810 modified "2023-10-18" @default.
- W4387420810 title "[Mechanism of Mongolian drug Naru-3 in initiation of neuroinflammation of neuropathic pain from MMP9/IL-1β signaling pathway]." @default.
- W4387420810 doi "https://doi.org/10.19540/j.cnki.cjcmm.20230216.401" @default.
- W4387420810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37802786" @default.
- W4387420810 hasPublicationYear "2023" @default.
- W4387420810 type Work @default.
- W4387420810 citedByCount "0" @default.
- W4387420810 crossrefType "journal-article" @default.
- W4387420810 hasAuthorship W4387420810A5008313987 @default.
- W4387420810 hasAuthorship W4387420810A5025951726 @default.
- W4387420810 hasAuthorship W4387420810A5037698336 @default.
- W4387420810 hasAuthorship W4387420810A5040524739 @default.
- W4387420810 hasAuthorship W4387420810A5048995986 @default.
- W4387420810 hasAuthorship W4387420810A5052308910 @default.
- W4387420810 hasAuthorship W4387420810A5055838753 @default.
- W4387420810 hasAuthorship W4387420810A5067661094 @default.
- W4387420810 hasAuthorship W4387420810A5074455515 @default.
- W4387420810 hasAuthorship W4387420810A5081239726 @default.
- W4387420810 hasAuthorship W4387420810A5082739478 @default.
- W4387420810 hasAuthorship W4387420810A5085052668 @default.
- W4387420810 hasAuthorship W4387420810A5086815085 @default.
- W4387420810 hasAuthorship W4387420810A5088404626 @default.
- W4387420810 hasConcept C118552586 @default.
- W4387420810 hasConcept C126322002 @default.
- W4387420810 hasConcept C15490471 @default.
- W4387420810 hasConcept C15744967 @default.
- W4387420810 hasConcept C169760540 @default.
- W4387420810 hasConcept C170493617 @default.
- W4387420810 hasConcept C172659308 @default.
- W4387420810 hasConcept C2776281502 @default.
- W4387420810 hasConcept C2776914184 @default.
- W4387420810 hasConcept C2777107010 @default.
- W4387420810 hasConcept C2779245659 @default.
- W4387420810 hasConcept C2780775167 @default.
- W4387420810 hasConcept C2781118164 @default.
- W4387420810 hasConcept C3673659 @default.
- W4387420810 hasConcept C42219234 @default.
- W4387420810 hasConcept C71924100 @default.
- W4387420810 hasConcept C87753298 @default.
- W4387420810 hasConcept C98274493 @default.
- W4387420810 hasConceptScore W4387420810C118552586 @default.
- W4387420810 hasConceptScore W4387420810C126322002 @default.
- W4387420810 hasConceptScore W4387420810C15490471 @default.
- W4387420810 hasConceptScore W4387420810C15744967 @default.
- W4387420810 hasConceptScore W4387420810C169760540 @default.
- W4387420810 hasConceptScore W4387420810C170493617 @default.
- W4387420810 hasConceptScore W4387420810C172659308 @default.
- W4387420810 hasConceptScore W4387420810C2776281502 @default.
- W4387420810 hasConceptScore W4387420810C2776914184 @default.
- W4387420810 hasConceptScore W4387420810C2777107010 @default.
- W4387420810 hasConceptScore W4387420810C2779245659 @default.
- W4387420810 hasConceptScore W4387420810C2780775167 @default.
- W4387420810 hasConceptScore W4387420810C2781118164 @default.
- W4387420810 hasConceptScore W4387420810C3673659 @default.
- W4387420810 hasConceptScore W4387420810C42219234 @default.
- W4387420810 hasConceptScore W4387420810C71924100 @default.
- W4387420810 hasConceptScore W4387420810C87753298 @default.
- W4387420810 hasConceptScore W4387420810C98274493 @default.
- W4387420810 hasIssue "15" @default.
- W4387420810 hasLocation W43874208101 @default.
- W4387420810 hasOpenAccess W4387420810 @default.
- W4387420810 hasPrimaryLocation W43874208101 @default.
- W4387420810 hasRelatedWork W2030131620 @default.
- W4387420810 hasRelatedWork W2042348308 @default.
- W4387420810 hasRelatedWork W2077481407 @default.
- W4387420810 hasRelatedWork W2090906051 @default.
- W4387420810 hasRelatedWork W2103552254 @default.
- W4387420810 hasRelatedWork W2136477585 @default.
- W4387420810 hasRelatedWork W2144190332 @default.
- W4387420810 hasRelatedWork W2411703793 @default.
- W4387420810 hasRelatedWork W2460583745 @default.
- W4387420810 hasRelatedWork W2792405982 @default.
- W4387420810 hasVolume "48" @default.
- W4387420810 isParatext "false" @default.
- W4387420810 isRetracted "false" @default.
- W4387420810 workType "article" @default.